Main > HEMATOLOGY > HyperEosinophilic Syndrome > Treatment > Co.: CH. Brand Imatinib

---

Co.: CH. Brand Imatinib's subsections
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Expiration Date: 2015. 01.04
Patent>Total USA No.: 3
Patent>UpDate: 2007. 01.23.
TradeMark (USA)
TradeMark (USA) Web-Site
UpDate: 2016. 07.06.

Co.: CH. Brand Imatinib's products
This section has no products